These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3929026)

  • 21. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51.
    Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA
    Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunofluorescence studies of Brucella. II. Demonstration in the organs of experimentally infected mice].
    Radu I; Pop A; Vasilescu T
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):41-50. PubMed ID: 4998678
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
    J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A solid phase assay with radioactively-labelled antibody for the detection of Brucella abortus.
    Wilson DV; Thornley MJ; Coombs RR
    J Med Microbiol; 1977 Aug; 10(3):281-92. PubMed ID: 408491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
    Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
    Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous lytic activity against allogeneic tumor cells and depression of specific cytotoxic responses in mice infected with Trypanosoma cruzi.
    Hatcher FM; Kuhn RE
    J Immunol; 1981 Jun; 126(6):2436-42. PubMed ID: 6785354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brucella melitensis B115-based complement fixation test to detect antibodies induced by Brucella rough strains.
    Adone R; Francia M; Ciuchini F
    J Appl Microbiol; 2008 Aug; 105(2):567-74. PubMed ID: 18355234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
    Oliveira SC; Harms JS; Banai M; Splitter GA
    Cell Immunol; 1996 Sep; 172(2):262-8. PubMed ID: 8964089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
    Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
    Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement activity of anti-brucella sera in experimental Brucella abortus infection in mice.
    Forget A; Riendeau C
    Rev Can Biol; 1977 Sep; 36(3):239-43. PubMed ID: 412235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective activity to murine experimental brucellosis conferred by monoclonal antibody ISS/32 anti-B. abortus.
    Adone R; Ciuchini F; Pistoia C; Marcon G; Piccininno G
    Zentralbl Veterinarmed B; 1991 Jul; 38(5):397-400. PubMed ID: 1718101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plaque-forming cells in mice after experimental infection with Brucella abortus.
    Schneerson-Porat S; Feinhaken D; Pinto M
    Infect Immun; 1978 Jul; 21(1):337-9. PubMed ID: 101461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of experimental brucellosis of mice and guinea pigs by rifampicin].
    Philippon A; Kazmierczak A; Plommet M; Marly J; Nevot P
    Dev Biol Stand; 1976; 31():279-86. PubMed ID: 816684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic analysis of cattle anti-Brucella abortus S45/20 non-agglutinating antibodies in antibody-dependent cell-mediated cytotoxicity.
    Cerone SI; Parma AE; Bowden RA; Santisteban CG
    Vet Microbiol; 1987 Mar; 13(3):273-9. PubMed ID: 3116750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunological enhancement phenomenon in experimental brucella infection of the chicks.
    Forget A; Borduas AG
    Int Arch Allergy Appl Immunol; 1977; 53(2):190-4. PubMed ID: 403146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytotoxic activity in mouse tumors by lymphocytes with anti-streptococcal specific antibodies].
    Fujioka T; Tanji S; Koike H; Kumagai K; Aoki H; Kubo T; Ohhori T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1243-7. PubMed ID: 3068321
    [No Abstract]   [Full Text] [Related]  

  • 40. Persistent plaque formation in experimental murine brucellosis.
    Schneerson-Porat S; Feinhaken D; Pinto M
    Comp Immunol Microbiol Infect Dis; 1983; 6(1):51-6. PubMed ID: 6402336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.